To include your compound in the COVID-19 Resource Center, submit it here.
A group of 12 U.S. House and Senate Democrats sent a Xtandi enzalutamide from Astellas Pharma Inc. (Tokyo:4503).
In January, two patient advocacy groups asked
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury